|
PLEKHA7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.17603712826531E-14 |
| Normal-vs-Stage2 |
2.48949999503978E-08 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.62447832963153E-12 |
| Stage1-vs-Stage2 |
6.547800E-01 |
| Stage1-vs-Stage3 |
7.88110000038422E-07 |
| Stage1-vs-Stage4 |
3.69930000000407E-05 |
| Stage2-vs-Stage3 |
4.637600E-03 |
| Stage2-vs-Stage4 |
6.663200E-03 |
| Stage3-vs-Stage4 |
7.213200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
1.002740E-03 |
| Normal-vs-Asian |
1.174220E-02 |
| Caucasian-vs-AfricanAmerican |
4.143500E-02 |
| Caucasian-vs-Asian |
1.952360E-01 |
| AfricanAmerican-vs-Asian |
9.796000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.11022302462516E-16 |
| Normal-vs-Female |
1.16570086916568E-11 |
| Male-vs-Female |
1.964830E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.42110000054008E-07 |
| Normal-vs-Age(41-60Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62436730732907E-12 |
| Normal-vs-Age(81-100Yrs) |
2.16849999999935E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.793850E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.821800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.380600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.061400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.301800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.777400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.990000E-01 |
| Normal-vs-Grade 2 |
6.66133814775094E-16 |
| Normal-vs-Grade 3 |
1.62447832963153E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
2.636400E-02 |
| Grade 1-vs-Grade 3 |
1.163710E-02 |
| Grade 1-vs-Grade 4 |
2.123000E-03 |
| Grade 2-vs-Grade 3 |
1.015950E-02 |
| Grade 2-vs-Grade 4 |
1.61010005328421E-09 |
| Grade 3-vs-Grade 4 |
7.72260000000413E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.96260033067131E-10 |
| Normal-vs-ccB subtype |
1.62436730732907E-12 |
| ccA subtype-vs-ccB subtype |
3.10862446895044E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
<1E-12 |
| Normal-vs-N1 |
6.41440234261381E-11 |
| N0-vs-N1 |
1.502430E-01 |
|
|
